J Korean Med Sci.  2007 Sep;22(Suppl):S5-S10. 10.3346/jkms.2007.22.S.S5.

Cancer Survival in Korea 1993-2002: A Population-Based Study

• Jung KW
• Yim SH
• Kong HJ
• Hwang SY
• Won YJ
• Lee JK
• Shin HR

• KMID: 1785782
• DOI: http://doi.org/10.3346/jkms.2007.22.S.S5

Abstract

Population-based survival reflect the average prognosis of unselected patients with a variety of natural histories as well as treatment patterns and are also useful for evaluating effectiveness and efficiency of cancer-directed health services in a given region. Although survival data have been reported based on hospital data, the survival data from population-based registry have been rarely reported in Korea. Based on the Korea National Cancer Incidence Database, we report the results from survival analysis for cancer patients diagnosed during 1993-2002 and followed up until 31 December 2005 at primary cancer sites. The five-year relative survival rates (RSR) were calculated using the Ederer II method. The Kaplan-Meier method was used to estimate median survival and the 95% confidence intervals. In males, the five-year RSR for all cancers was 32.5% during 1993-1997 and was 37.8% during 1998-2002. In females, the five-year RSR for all cancers was 53.7% during 1993-1997 and was 57.0% during 1998-2002. The largest improvement in survival was shown in prostate cancer in males and breast and stomach cancer in females. The median survival durations were 16.3 months in males and 81.6 months in females. This result will be useful for evaluation of cancer treatment outcomes in Korea.

Keyword

Cancer Registry; Survival; Korea

MeSH Terms

Databases, Factual
Epidemiologic Factors
Female
Humans
Kaplan-Meiers Estimate
Korea/epidemiology
Male
Neoplasms/*mortality
Registries
Survival Rate

Figure

• 

  Fig. 1 Five-year relative survival of 10 major cancers in Korea, male, 1993-2002.

• 

  Fig. 2 Five-year relative survival of 10 major cancers in Korea, female, 1993-2002.

Reference

1. Bae JM, Won YJ, Jung KW, Suh KA, Yun YH, Shin MH, Ahn YO, Lee DH, Shin HR, Ahn DH, Oh DK, Park JG. 134 KCCR-affiliated Hospitals. Survival of Korean cancer patients diagnosed in 1995. Cancer Res Treat. 2002. 34:319–325.

2. Lee KH, Kwon Y, Lee TY. Survival rate and factors affecting survival among patients of lung cancer lived in Daejeon city. Korean J Epidemiol. 2003. 25:62–75.

3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, Noh HI, Pisani P, Park JG, Ahn YO, Lee SY, Lee CW, Woo ZH, Lee TY, Choi JS, Yoo CI, Bae JM. Nationwide cancer incidence in Korea, 1999-2001; First result using the National Cancer Incidence Database. Cancer Res Treat. 2005. 37:325–331.

4. Parkin DM, Hakulinen T. Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ. 1991. 95:159–176.

5. NCHS Definitions: Relative Survival Rate. National Center for Health Statistics. accessed 25 May 2006. Available at http://www.cdc.gov/nchs/datawh/nchsdefs/relsurvrate.htm.

6. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. End Results Evaluation Section. 1959. Bethesda MD: National Cancer Institute.

7. Dickman PW. accessed 07 June 2006. Available at http//www.pauldickman.com.

8. Greenwood M. Great Britain, Her Majesty's Stationery Office. The errors of sampling of the survivorship table. Reports on public health and medical subjects. 1926. vol 33. London, U.K: Her Majesty's Stationery Office.

9. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer. 1996. 78:2004–2010.

10. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Seow A, Lee HP. Population-based cancer survival in singapore, 1968 to 1992: an overview. Int J Cancer. 2001. 93:142–147.

11. Swaminathan R, Black RJ, Sankaranarayanan R. Database on cancer survival from developing countries. IARC Sci Publ. 1998. 145:19–25.

12. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003. 14:Suppl 5. v128–v149.

13. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer. 1998. 34:2271–2278.

14. Evans HS, Moller H. Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol. 2003. 43:337–341.

15. Ministry of Health and Welfare. 2001 Annual Report of National Cancer Registration. 2005.

16. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006. 260:103–117.

17. Monnet E, Faivre J, Raymond L, Garau L. Comparability of colorectal cancer survival data in three European population-based registries. Eur J Cancer Prev. 1998. 7:127–134.

18. Prior P, Woodman CB, Collins S. International differences in survival from colon cancer: more effective care versus less complete cancer registration. Br J Surg. 1998. 85:101–104.

19. Berrino F, Estève J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. IARC Sci Publ. 1995. 132:1–14.

20. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2003. 2006. accessed 24 November 2006. Bethesda, MD: National Cancer Institute;Available at http://seer.cancer.gov/csr/1975_2003/.

21. Tsukuma H, Ajiki W, Ioka A, Oshima A. Research Group of Population-Based Cancer Registries of Japan. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006. 36:602–607.